Blog Teasers no sidebar

The FDA has declared the shortage of Ozempic and similar medications to be over, a decision that ends the legal ability of compounding pharmacies to produce and sell off-brand versions. ...

Read more

As of April 2025, the Food & Drug Administration (FDA) has approved a medication called Dupixent for the treatment of chronic spontaneous urticaria. This biologic drug, generically known as dupilumab, ...

Read more

Generic and biosimilar products have long offered a more affordable alternative to brand-name medications. For many people, these options are the only way they can receive the prescriptions they need ...

Read more

The Trump administration has had a significant impact on many industries, including drug development. A primary focus has been on reducing drug prices, and a variety of strategies aim to ...

Read more

The drug approval process is a lengthy one that can take anywhere from months to years, but as the COVID-19 pandemic proved, it’s not always possible to wait that long ...

Read more